SCHEMBL13907693

SCHEMBL13907693

CN(Cc1cc(N)cc(Br)c1N)C1CCCCC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 4/20 0.79
▸ ABCB11 O95342 1/20 0.79
▸ ADORA3 P0DMS8 1/20 0.79
▸ AR P10275 1/20 0.79
▸ SLC6A2 P23975 1/20 0.79
▸ PDE4A P27815 1/20 0.79
▸ SLC6A4 P31645 1/20 0.79
▸ SLC6A3 Q01959 1/20 0.79
▸ KCNH2 Q12809 1/20 0.79
▸ SIGMAR1 Q99720 1/20 0.79
▸ LMNA P02545 3/20 0.77
▸ CYP3A4 P08684 1/20 0.77
▸ HTT P42858 1/20 0.77
▸ HRH3 Q9Y5N1 2/20 0.43
▸ HRH4 Q9H3N8 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NOS3 P29474 2/20 0.40
▸ NOS1 P29475 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromhexine SCHEMBL19059 0.88 CYP2D6 (1.00) CYP2D6ABCB11ADORA3ARSLC6A2
Bromhexine SCHEMBL29379593 0.88 CYP2D6 (1.00) CYP2D6ABCB11ADORA3ARSLC6A2
Bromhexine SCHEMBL10704011 0.87 LMNA (1.00) CYP2D6ABCB11ADORA3ARSLC6A2
Bromhexine SCHEMBL99613 0.87 LMNA (1.00) CYP2D6ABCB11ADORA3ARSLC6A2
SCHEMBL11622934 0.87 CYP2D6 (0.77) CYP2D6ABCB11ADORA3ARSLC6A2
Bromhexine SCHEMBL18548828 0.87 CYP2D6 (0.97) CYP2D6ABCB11ADORA3ARSLC6A2
SCHEMBL28000432 0.86 ABCB11 (0.75) CYP2D6ABCB11ADORA3ARSLC6A2
SCHEMBL11620394 0.86 CYP2D6 (0.75) CYP2D6ABCB11ADORA3ARSLC6A2
SCHEMBL30080254 0.86 ABCB11 (0.75) CYP2D6ABCB11ADORA3ARSLC6A2
SCHEMBL11618532 0.85 CYP2D6 (0.73) CYP2D6ABCB11ADORA3ARSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034029-A2 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-19 — — WO disclosed
Send feedback